MyFinsight
Home
Blog
About
Contact
Download
Download image
Change in fair value of
warrant liability
$1,895,865
Change in fair value of
investment - qcls
$1,725,000
Change in fair value of
derivative liability
$557,000
Interest income
$230,668
Total other income and
(expense), net
$2,864,962
Change in fair value of
warrants - qcls
-$1,200,000
Change in fair value of
warrant asset - femasys
-$214,000
Unrealized loss on
marketable securities
-$128,939
Other expense
-$632
Net income (gain)
attributable to common...
-$1,556,255
Net income (gain)
$746,860
Loss from operations
-$2,118,102
Preferred stock accretion
$2,204,657
Preferred stock dividends
$98,458
Total operating
expenses
$2,118,102
General and
administrative
$2,024,989
Research and development
costs
$93,113
Back
Back
Income Statement
source: myfinsight.com
PharmaCyte Biotech, Inc. (PMCB)
PharmaCyte Biotech, Inc. (PMCB)